HaploPharma Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

HaploPharma General Information

Description

Provider of biotechnology services intended to serve the pharmaceutical companies. The company's services offer planning, research, development, and dissemination of pharmaceuticals, diagnostics, health foods, diagnostic equipment, and medical equipment for pharmaceutical research, development, and medical diagnostics, enabling clients to have health support services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 468-1 Aramaki Aoba
  • Aoba-ku, Sendai-shi
  • Miyagi Prefecture
  • Japan
+81 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HaploPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2007 Completed Generating Revenue
To view HaploPharma’s complete valuation and funding history, request access »

HaploPharma Executive Team (4)

Name Title Board Seat Contact Info
Yasuhisa Nemoto Ph.D President
Mitsuo Itakura Ph.D Chief Scientific Officer & Supervisory Board Member
Koichi Nomoto Director, Finance and Administration & Member of Supervisory Board
Yoshihiro Ohtaki Ph.D Chief Executive Officer & Supervisory Board Member
To view HaploPharma’s complete executive team members history, request access »

HaploPharma Board Members (5)

Name Representing Role Since
Hiroshi Gushima Ph.D Self Chairman 000 0000
Koichi Nomoto HaploPharma Director, Finance and Administration & Member of Supervisory Board 000 0000
Mitsuo Itakura Ph.D HaploPharma Chief Scientific Officer & Supervisory Board Member 000 0000
Shumpei Ishikawa Ph.D HaploPharma Supervisory Board Member and Senior Scientific Advisor 000 0000
Yoshihiro Ohtaki Ph.D Self Chief Executive Officer & Supervisory Board Member 000 0000
To view HaploPharma’s complete board members history, request access »

HaploPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HaploPharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioFrontier Partners Venture Capital Minority 000 0000 000000 0
To view HaploPharma’s complete investors history, request access »